Evidence map›Paper›PMID 40781740›Full record

ArticleMedical physics2025

Predicting near-complete pathological response to (chemo)radiotherapy in patients with rectal cancer: A federated learning study.

Pedro Mateus, Mariachiara Savino, Nikola Dino Capocchiano, Maaike Berbee, Maria Antonietta Gambacorta, Giuditta Chiloiro, Yves C P Willems, Andrea Damiani, Biche Osong, Andre Dekker and 1 more

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pedro MateusDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Mariachiara SavinoFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Nikola Dino CapocchianoFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Maaike BerbeeDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Maria Antonietta GambacortaFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Giuditta ChiloiroFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Yves C P WillemsDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Andrea DamianiFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Biche OsongDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Andre DekkerDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Inigo BermejoDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.

Funding

Bowel Research UK
6 · The paper itself

Abstract

backgroundOrgan preservation in patients with locally advanced rectal cancer has attracted interest due to improved quality of life and functional outcomes compared with total mesorectal excision. Hence, patients who achieve clinical complete response (cCR) after (chemo)radiotherapy are offered a watch-and-wait strategy. Those who are likely to fall short of the strict criteria of cCR and only achieve near complete response (NCR) might benefit from radiation boosting to avoid surgery. PURPOSE: To develop a prediction model that estimates the probability of NCR trained on data from different clinics.

methodsWe used data from two clinics (Maastro and Gemelli) on 1305 patients. We set up and used a federated learning infrastructure to leverage patient data from the clinics without transferring it. We used Bayesian networks for their capacity to combine expert knowledge with data and their ability to handle missing data. In this article, we propose a novel federated learning algorithm for Bayesian networks. In addition, we explore different approaches to handle missing data and train the models, combining expert elicited structures and those learnt from data. The discriminative performance of the models is reported using the area under the ROC curve (AUC).

resultsThe model trained on data from both clinics and a structure learnt from data performed well (AUC 0.77). When using a structure elicited from an expert, the performance of the model decreased (AUC 0.68). Fine-tuning the expert structure with data led to a middle ground performance (AUC 0.72). Models trained on data from a single clinic failed to generalize when tested on data from the other clinic (AUCs 0.50 and 0.59).

conclusionsThe model trained with federated learning showed good discriminative performance, which indicates that it could be useful to identify which patients with rectal cancer would benefit the most from a radiotherapy boost. This study shows that federated learning has the potential to lead to better models by allowing access to more data.

Indexed as

ChemoradiotherapyMachine LearningRectal NeoplasmsBayes TheoremFederated LearningHumansTreatment Outcomeartificial intelligencefederated learningprediction modelRadiotherapy

Identifiers

PMID40781740
PMCPMC12334808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.